Webinars and Videos
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
11: Implementing Adaptive Trials
In Episode 11 of "In the Interim...", host Scott Berry discusses the nuances of implementing adaptive clinical trials with Dr. Anna McGlothlin and Dr. Michelle Detry from Berry Consultants.
10: Revisiting Seamless 2/3 Trial for GLP-1 Agonist
In this episode of "In the Interim..." we revisit the ground-breaking seamless phase 2/3 clinical trial for the GLP-1 agonist, dulaglutide—better known as Trulicity.
9: I-SPY 2 to GBM AGILE and Beyond
In this episode of "In the Interim...," we sit down with Dr. Meredith Buxton to explore the evolution of platform trials from I-SPY 2 to GBM AGILE and Beyond.
Why Simulate?
In this FACTS Webinar, Dr. Mike Krams of Berry Consultants hosts a panel of experts to discuss, “Why Simulate?”
8: External Data in Clinical Trials
In this episode of "In the Interim...," Scott Berry and Kert Viele navigate the nuanced debate surrounding the integration of external data in clinical trials.
7: Remembering Jimmie Savage
In this episode of "In the Interim," Don Berry shares the life and work of Jimmie Savage, his advisor and a legendary figure in Bayesian statistics.
No results found.
There are no results with this criteria. Try changing your search.